GSK has concluded the acquisition of efimosfermin alfa, an investigational therapeutic for serious liver disease, from Boston Pharmaceuticals ...

London: GSK plc has concluded the acquisition of efimosfermin alfa from Boston Pharmaceuticals in a USD 2 billion ...

GSK completes $2 billion acquisition of efimosfermin from Boston Pharmaceuticals: London, UK Wednesday, July 9, 2025, 09:00 Hrs [IST] GSK plc announced the completion of its previ ...

Cycle Pharmaceuticals announced the launch of HARLIKU, the first and only FDA-approved treatment for reducing urinary ...

Presentations highlight clinically meaningful reductions in BMI in patients with acquired hypothalamic obesity – - Full data ...

Abbott is doubling down on the structural heart space, as it aims to gain ground in valve replacements following the recent ...

The project marks a significant step forward in addressing the critical need for purpose-built life sciences manufacturing ...

A Cambridge biotech company is preparing to lay off its entire staff of more than 300 after being acquired by another firm.

HYDERABAD, India — (AP) — The death toll from Monday's massive explosion and fire at a pharmaceutical factory in India’s ...

Invagen Pharmaceuticals Inc. will add 70 medical manufacturing jobs with a state tax incentive program worth almost $1.8 million.

The Boston Arts Academy Foundation closed its Building Our Future fundraising campaign, surpassing its $35 million goal, thanks to twin $1 million donations – one from Vertex Pharmaceuticals ...